On May 15, 2023, the WeChat official account "HClinicalResearch"(Hanson临床科研), managed primarily by the Healsan team, surpassed the 200,000 follower milestone. This account primarily focuses on leveraging big data analytics to identify renowned physician-scientists, highlight significant research articles, and spotlight the latest breakthroughs in biomedical technology.
January 04, 2023
The combination of medical big data analysis with clinical research has produced remarkable efficacy. This is evident in the green card application process: the approval rate for cases submitted by Healsan (医路移民) reached an astounding 100% in 2022. This is because we 1) identify the contributions of applicants through big data analysis, 2) have medical scientists draft the green card application materials, and 3) the review and refinement are completed by American doctor-scientists.
October 08, 2023
After a biopharmaceutical company finalizes its product's clinical trials, timely publication of the research is crucial for advancing the drug approval process. This instance reveals that Hanson's clinical research endeavors are capable of delivering top-tier papers with impressive speed, tailored to client specifications.
On November 24, 2021, Healsan established, "Shanghai Healsan Medical Consulting Co., Ltd," (上海恒祥医药咨询有限公司)in Shanghai, China.
Copyright © 2023 Healsan - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.